HOME   SITE MAP   CONTACT US

 Back

SCYNEXIS to Lead Discussion of Software System
With Local Global Health Group

RESEARCH TRIANGLE PARK, NC (May 24, 2010) - Drug discovery and development company SCYNEXIS on Thursday will lead a discussion with local global health organizations and the general public about the company's use of its proprietary SaaS platform system to help researchers in the development of new therapies for so-called neglected diseases in the developing world.

The breakfast presentation to members of the Triangle Global Health Consortium will be Thursday at 7:30 a.m. at the North Carolina Biotechnology Center.

SCYNEXIS' HEOS® System is a web-based drug research information software that allows researchers dispersed around the world to collaborate in the collection of data for discovery of drugs for treatment of tropical disease such as malaria, sleeping sickness, leashmaniasis and other neglected diseases.

SCYNEXIS is currently working with organizations such as Medicines for Malaria Venture (MMV), Drugs for Neglected Diseases initiative (DNDi) and the WHO Tropical Diseases Research organization in efforts to develop therapies for global diseases that often have been overlooked in development of drugs by global pharmaceutical companies.

Leading the discussion of the SCYNEXIS system will be Frederic Bost who is director of Information Systems for the company where he is responsible for the creation and maintenance of HEOS® and other software solutions.

Many different public and private organizations around the globe are collaborating on neglected diseases, requiring a secure, multi-organization data-management solution that facilities collaboration. The discussion will review solutions offered by Software as a Service (SaaS) web-based platforms such as HEOS®.

"The complex process of transforming a "hit" into a clinical drug candidate involves data generated by a broad range of sources and our HEOS® system has proven very effective in the capture, storage and analysis of research data by geographically dispersed researchers working on treatments for neglected diseases," said Bost.

Visit www.triangleglobalhealth.org to register to attend the breakfast.


About SCYNEXIS
SCYNEXIS delivers integrated, efficient and innovative drug discovery and development solutions to our global health and pharmaceutical partners. Our record of success is exemplified by the delivery of 11 pre-clinical drug candidates over the last five years. SCYNEXIS’ teams are tailored to be especially effective in moving customer projects from concept to clinic, utilizing powerful proprietary technologies such as the HEOS® SaaS Software Platform for comprehensive drug discovery information management and the MEDCHEMFACTORY® High-Throughput Synthesis and Purification Platform.

Founded in 2000, SCYNEXIS is located in Research Triangle Park, N.C. SCYNEXIS is registered with both the FDA and DEA. Please visit our website at www.scynexis.com.


About The Triangle Global Health Consortium
The aim of the Triangle Global Health Consortium is to establish North Carolina as an international center for research, training, education, advocacy and business dedicated to improving the health of the world's communities. We seek to engage academic, governmental, business and nonprofit organizations in this collaborative effort. Visit www.triangleglobalhealth.org.


For further information, please contact:

SCYNEXIS, Inc.
Terry Marquardt
Executive Director, Market Development & Communications
terry.marquardt@scynexis.com
Tel: +1-919-544-8603